These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8671837)

  • 21. A caveat in the management of acute gout.
    Varughese GI; Varghese AI; Tahrani AA
    Am J Med; 2007 Nov; 120(11):e31; author reply e33. PubMed ID: 17976406
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of idiopathic pulmonary fibrosis with colchicine].
    Undurraga A; Meneses M; Sabbagh E; Oyarzún M
    Rev Med Chil; 1998 Nov; 126(11):1345-53. PubMed ID: 10349178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The progression of kidney failure].
    Ritz E
    Dtsch Med Wochenschr; 1993 May; 118(18):593-4. PubMed ID: 8495642
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal fibrosis and the renin-angiotensin system.
    Fogo AB
    Adv Nephrol Necker Hosp; 2001; 31():69-87. PubMed ID: 11692472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathways to renal fibrosis.
    el Nahas AM
    Exp Nephrol; 1995; 3(2):71-5. PubMed ID: 7773639
    [No Abstract]   [Full Text] [Related]  

  • 26. [Multi-systemic toxicity of colchicine and renal failure: apropos of a case].
    Rosset L; Descombes E; Fellay G; Regamey C
    Schweiz Med Wochenschr; 1998 Dec; 128(49):1953-7. PubMed ID: 9887475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colchicine myoneuropathy in chronic renal failure patients with gout.
    Lai IC; Cheng CY; Chen HH; Chen WY; Chen PY
    Nephrology (Carlton); 2006 Apr; 11(2):147-50. PubMed ID: 16669978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colchicine prescribing and safety monitoring in patients with gout.
    Ly J; Gow P; Dalbeth N
    N Z Med J; 2007 Nov; 120(1265):U2808. PubMed ID: 18264188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy.
    Windt WA; Tahara A; Kluppel AC; de Zeeuw D; Henning RH; van Dokkum RP
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):217-24. PubMed ID: 17347933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyte is the major culprit accounting for the progression of chronic renal disease.
    Kriz W
    Microsc Res Tech; 2002 May; 57(4):189-95. PubMed ID: 12012382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of colchicine effect in the treatment of asbestosis and idiopathic pulmonary fibrosis.
    Addrizzo-Harris DJ; Harkin TJ; Tchou-Wong KM; McGuinness G; Goldring R; Cheng D; Rom DW
    Lung; 2002; 180(2):61-72. PubMed ID: 12172901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colchicine: time to rethink.
    Varughese GI; Varghese AI; Tahrani AA
    N Z Med J; 2007 Feb; 120(1249):U2429. PubMed ID: 17308565
    [No Abstract]   [Full Text] [Related]  

  • 33. Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient.
    Mitroulis I; Papadopoulos VP; Konstantinidis T; Ritis K
    Neth J Med; 2008 Dec; 66(11):489-91. PubMed ID: 19075317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colchicine in Renal Diseases: Present and Future.
    Marinaki S; Skalioti C; Boletis JN
    Curr Pharm Des; 2018; 24(6):675-683. PubMed ID: 29359660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular lipid metabolism and the role of lipids in progressive renal disease.
    Abrass CK
    Am J Nephrol; 2004; 24(1):46-53. PubMed ID: 14707435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic application of colchicine in clinical practice].
    Lewicki M; Kotyla PJ; Kucharz EJ
    Pol Arch Med Wewn; 2005 Apr; 113(4):382-6. PubMed ID: 16209255
    [No Abstract]   [Full Text] [Related]  

  • 37. Probucol suppresses the development of chronic renal failure in Dahl salt-sensitive rats: an animal model of spontaneous focal and segmental glomerulosclerosis.
    Naito H; Hirano T
    Nephron; 1994; 67(1):125-6. PubMed ID: 8052359
    [No Abstract]   [Full Text] [Related]  

  • 38. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2020; 109(13):1087-1088. PubMed ID: 33050820
    [No Abstract]   [Full Text] [Related]  

  • 39. Does colchicine also induce a clearance of the established amyloid deposits?
    Tuğlular S; Bihorac A; Ozener IC; Akoğlu E
    Nephrol Dial Transplant; 1999 Apr; 14(4):1042-3. PubMed ID: 10328512
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of acne vulgaris with colchicine.
    Sadjadi SJ; Moshir M
    Acta Derm Venereol; 1998 Sep; 78(5):388. PubMed ID: 9779268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.